Abstract
Background: Neoadjuvant (chemo)radiation (n(C)RT) in combination with total mesorectal excision (TME) for primary rectal cancer is associated with low rates of locally recurrent rectal cancer (LRRC), but can jeopardize LRRC management as there are limitations to the radiation dose. The primary aim of this study was to provide an overview of LRRC after TME in the Netherlands, with a secondary focus on the impact of n(C)RT for primary rectal cancer on outcomes of LRRC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
